Childhood-Onset Essential Hypertension Natural History Study
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Study ID
- NCT06778239
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 99 Years
- Healthy Volunteers
- Not accepted
Study Details
Background: Childhood-onset essential hypertension (COEH) is high blood pressure that develops in children and teens. High blood pressure is a major risk factor for heart disease. COEH is more likely to be caused by changes in genes rather than by factors like stress or diet. Researchers want to learn more about how changes in genes relate to COEH. They hope to use that information to develop better treatments for children with high blood pressure. Objective: This natural history study will look for genes and gene changes that may lead to COEH. Eligibility: People aged 2 years and older with COEH or who had COEH when they were children. Healthy relatives of those with COEH are also needed. Design: Participants will have one clinic visit per year for up to 10 years. All participants will have a physical exam. They will provide samples of blood and urine. At their first visit, they will have a swab (like a Q-tip) rubbed between their gums and cheeks. They may agree to having a skin biopsy; a piece of skin about the size of a pencil eraser will be removed. Affected participants aged 2 to 17 years old will have additional tests: * They will have sensors placed on their skin to look at their blood vessels and see how blood is moving in their bodies. * They will lie or stand while a machine measures the amount of fat and muscle in their bodies. * They will have an ultrasound; a wand will be rubbed against their skin to take pictures of their kidneys. Other things are optional for all participants: * They may have photographs taken of their bodies. * They may have tests of their heart function. * They may have different types of imaging scans....
Key Dates
- Start date
- May 30, 2025
- Status verified
- May 2026
- Primary completion
- Dec 9, 2034
- Completion
- Dec 9, 2034
Study Design
- Enrollment
- 2,300 participants (estimated)
Arms
- Arm: AffectedStudy participants that are 2-17 years old and have COEH or participants that are 18+ years old that were diagnosed with COEH when they were children.
- Arm: UnaffectedStudy participants that are 2+ years old and have never been diagnosed with COEH.
Primary Outcome Measure
Find all genes that cause COEH. [ Time Frame: 10 years ]
Central Contacts
- Emilyn C Banfield(240) 328-0965
- Neil A Hanchard, M.D.(301) 594-2151
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 |
Find similar trials in Bethesda, MD
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Clinical and Molecular Characteristics of Primary Aldosteronism in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona